Free Trial
NASDAQ:MEDP

Medpace (MEDP) Stock Price, News & Analysis

Medpace logo
$323.50 -4.74 (-1.44%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$323.69 +0.19 (+0.06%)
As of 07/11/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Medpace Stock (NASDAQ:MEDP)

Key Stats

Today's Range
$320.94
$330.65
50-Day Range
$289.22
$328.24
52-Week Range
$250.05
$459.77
Volume
293,644 shs
Average Volume
377,752 shs
Market Capitalization
$9.30 billion
P/E Ratio
24.69
Dividend Yield
N/A
Price Target
$344.82
Consensus Rating
Hold

Company Overview

Medpace Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

MEDP MarketRank™: 

Medpace scored higher than 85% of companies evaluated by MarketBeat, and ranked 136th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medpace has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on 3 buy ratings, 11 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medpace has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medpace's stock forecast and price target.
  • Earnings Growth

    Earnings for Medpace are expected to grow by 11.15% in the coming year, from $12.29 to $13.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medpace is 24.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medpace is 24.69, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.96.

  • Price to Earnings Growth Ratio

    Medpace has a PEG Ratio of 5.94. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medpace has a P/B Ratio of 12.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Medpace's valuation and earnings.
  • Percentage of Shares Shorted

    14.02% of the float of Medpace has been sold short.
  • Short Interest Ratio / Days to Cover

    Medpace has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Medpace has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Medpace does not currently pay a dividend.

  • Dividend Growth

    Medpace does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.02% of the float of Medpace has been sold short.
  • Short Interest Ratio / Days to Cover

    Medpace has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Medpace has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Medpace has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Medpace this week, compared to 12 articles on an average week.
  • Search Interest

    Only 1 people have searched for MEDP on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Medpace to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medpace insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $516,716.00 in company stock.

  • Percentage Held by Insiders

    20.30% of the stock of Medpace is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    77.98% of the stock of Medpace is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medpace's insider trading history.
Receive MEDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medpace and its competitors with MarketBeat's FREE daily newsletter.

MEDP Stock News Headlines

FY2025 EPS Estimates for Medpace Lifted by Leerink Partnrs
MEDP - Medpace Holdings Inc Executives | Morningstar
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
MEDP - Medpace Holdings Inc Valuation | Morningstar
See More Headlines

MEDP Stock Analysis - Frequently Asked Questions

Medpace's stock was trading at $332.23 at the beginning of the year. Since then, MEDP shares have decreased by 2.6% and is now trading at $323.50.

Medpace Holdings, Inc. (NASDAQ:MEDP) released its quarterly earnings results on Monday, April, 21st. The company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.06 by $0.61. The firm had revenue of $558.57 million for the quarter, compared to analysts' expectations of $528.38 million. Medpace had a trailing twelve-month return on equity of 54.36% and a net margin of 19.31%.
Read the conference call transcript
.

Medpace (MEDP) raised $150 million in an initial public offering (IPO) on Thursday, August 11th 2016. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Top institutional shareholders of Medpace include Annex Advisory Services LLC (0.33%), Swedbank AB (0.25%), Abacus FCF Advisors LLC (0.06%) and Wealth Enhancement Advisory Services LLC (0.02%). Insiders that own company stock include Medpace Investors, Llc, August J Troendle, Susan E Burwig, Stephen P Ewald, Kevin M Brady, Fred B Davenport Jr, Ashley M Keating and Robert O Kraft.
View institutional ownership trends
.

Shares of MEDP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medpace investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), McKesson (MCK), Arista Networks (ANET), Adobe (ADBE) and ServiceNow (NOW).

Company Calendar

Last Earnings
4/21/2025
Today
7/11/2025
Next Earnings (Confirmed)
7/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:MEDP
CIK
1668397
Employees
5,900
Year Founded
N/A

Price Target and Rating

High Price Target
$432.00
Low Price Target
$300.00
Potential Upside/Downside
+6.6%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$13.10
Trailing P/E Ratio
24.69
Forward P/E Ratio
26.32
P/E Growth
5.77
Net Income
$404.39 million
Net Margins
19.31%
Pretax Margin
22.32%
Return on Equity
54.36%
Return on Assets
20.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.73
Quick Ratio
0.73

Sales & Book Value

Annual Sales
$2.11 billion
Price / Sales
4.41
Cash Flow
$14.07 per share
Price / Cash Flow
23.00
Book Value
$26.56 per share
Price / Book
12.18

Miscellaneous

Outstanding Shares
28,740,000
Free Float
22,907,000
Market Cap
$9.30 billion
Optionable
Optionable
Beta
1.47

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MEDP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners